SMC
GILD icon

Smith, Moore & Co’s Gilead Sciences GILD Stock Holding History

Smith, Moore & Co’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$205K Sell
1,474
-210
-12% -$29.4K 0.01% 534
2025
Q4 		$207K Sell
1,684
-397
-19% -$48.2K 0.02% 502
2025
Q3 		$231K Buy
2,081
+6
+0.3% +$682 0.02% 474
2025
Q2 		$230K Sell
2,075
-55
-3% -$5.85K 0.02% 456
2025
Q1 		$239K Sell
2,130
-1,000
-32% -$103K 0.02% 425
2024
Q4 		$289K Buy
3,130
+16
+0.5% +$1.44K 0.03% 377
2024
Q3 		$261K Buy
3,114
+21
+0.7% +$1.6K 0.02% 385
2024
Q2 		$212K Sell
3,093
-28
-0.9% -$1.87K 0.02% 414
2024
Q1 		$229K Buy
3,121
+215
+7% +$16.5K 0.02% 385
2023
Q4 		$235K Sell
2,906
-14
-0.5% -$1.09K 0.03% 368
2023
Q3 		$219K Buy
2,920
+1
+0% +$77 0.03% 353
2023
Q2 		$225K Buy
2,919
+151
+5% +$12K 0.03% 360
2023
Q1 		$230K Hold
2,768
– – 0.03% 345
2022
Q4 		$238K Buy
+2,768
New +$219K 0.03% 331
2017
Q4 		– Sell
-3,275
Closed -$265K – 307
2017
Q3 		$265K Buy
3,275
+129
+4% +$9.86K 0.08% 239
2017
Q2 		$223K Buy
3,146
+1
+0% +$67 0.07% 217
2017
Q1 		$214K Buy
3,145
+294
+10% +$20.7K 0.08% 217
2016
Q4 		$204K Sell
2,851
-34
-1% -$2.53K 0.08% 214
2016
Q3 		$228K Sell
2,885
-697
-19% -$56.6K 0.09% 190
2016
Q2 		$299K Sell
3,582
-54
-1% -$4.79K 0.12% 157
2016
Q1 		$334K Buy
3,636
+1,367
+60% +$123K 0.14% 137
2015
Q4 		$230K Buy
+2,269
New +$236K 0.11% 155

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Smith, Moore & Co's GILD Position: Q1 2026 in Review

Smith, Moore & Co reduced its Gilead Sciences (GILD) stake by 12% in Q1 2026, selling an estimated $29.4K and leaving 1,474 shares worth $205K. The position accounts for 0.01% of the portfolio, ranked #534.

Smith, Moore & Co first reported a position in GILD in Q4 2015 and has held it in 22 quarters since. The position peaked at $334K in Q1 2016. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Smith, Moore & Co held 1,474 shares of Gilead Sciences worth $205K as of Q1 2026.
  • Smith, Moore & Co sold 210 Gilead Sciences shares in Q1 2026, an estimated $29.4K.
  • Gilead Sciences made up 0.01% of Smith, Moore & Co's portfolio in Q1 2026, its #534 holding.
  • Smith, Moore & Co first reported a position in Gilead Sciences in Q4 2015 and has held it in 22 quarters since.
  • Smith, Moore & Co's Gilead Sciences position peaked at $334K in Q1 2016.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Smith, Moore & Co's 13F filing for Q1 2026, filed 5 May 2026.